NCT03968211View on ClinicalTrials.gov

Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency

PHASE1CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Immune Deficiency

Interventions

BIOLOGICAL

Salmonella typhi polysaccharide vaccine

Salmonella typhi polysaccharide vaccine

Trial Locations (1)

22908

University of Virginia Health System, Charlottesville

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

CSL Behring

INDUSTRY

collaborator

Jeffrey Modell Foundation

UNKNOWN

lead

University of Virginia

OTHER